Invitation to Episurf Medical’s Q4 2020 presentation

Episurf Medical hereby invites you to a webcasted presentation in connection with the publishing of the Q4 report, the fourth quarterly report for the fiscal year 2020. The report will be published at 08.30 (CET) on February 19th and available as of this time at www.episurf.com.

The presentation will be held in English by CEO Pål Ryfors, and afterwards questions are invited.

Date: February 19th 2021
Start time: 10:00 (CET)
Location: https://www.finwire.tv/webcast/episurf/episurf-webcast/

An on-demand version of the webcast will be available at Episurf Medical’s website after closing of the presentation.

Questions are welcome in advance by e-mail to: ir@episurf.com.

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.